EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SUMOylated DDX3 Promotes HBV Replication and Tumor Growth of Hepatocellular Carcinoma via TRIM28‐DDX3‐KLF4α Signaling Axis

Yanfang Yang iD, Ting Kong, Binghan Wang, Xiaoli Jin iD, Lan Huang, Nan Zhang, Siyu Tang, Samina Ejaz Syed iD, Shufang Liang iD

Advanced Science · 03.11.2026

DOI: 10.1002/advs.78603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 03.11.2026. Verfasst von Yanfang Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Strategic Cooperation Project between Sichuan University and Suining Municipal People's Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DDX3 has dual biological functions of regulating cell proliferation and antiviral effects. Herein, we focus on SUMOylation‐mediated DDX3 in the interplay from hepatitis B virus (HBV) infection to HBV‐associated hepatocellular carcinoma (HBV‐HCC) progression. We identified dynamic regulation of SUMOylation and DeSUMOylation of DDX3 at four key lysine (K) residues (K81/K208/K215/K564) in response to HBV infection. During the early stage of HBV acute infection, SENP1 interacts with DDX3 to keep DDX3 deSUMOylation for inhibiting HBV replication. During persistent HBV replication, as SENP1 downregulation and HBV polymerase accumulation, DDX3 disassociates with SENP1 to bind with TRIM28, which induces DDX3 SUMOylation. Meanwhile, SUMOylated DDX3 enhances alternative splicing of KLF4 mRNAs to generate KLF4α isoform that involves in Cyclin D1‐mediated cell cycle progression, weakens tumor suppressor function of DDX3 and promotes HBV‐HCC. Moreover, DDX3 expression is positively correlated with KLF4 mRNA, and high DDX3 level with low TRIM28 expression indicates a better overall survival for HBV‐HCC patients. Our findings reveal the dynamic regulation between SUMOylation and deSUMOylation of DDX3, including mediating HBV gene transcription, virus antigen secretion, and cell proliferation. Furthermore, the TRIM28‐DDX3‐KLF4 axis as a novel therapeutic target for HBV‐HCC, exhibiting the dual ability to inhibit tumor progression and disrupt the HBV–host interaction.

Schlagwörter

Stichwörter der Autor:innen

DDX3HBV‐associated hepatocellular carcinomaHepatitis B virusSUMOylationdeSUMOylation

Autor:innen und Institutionen

  • Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Central Laboratory, NHC Key Laboratory of Pulmonary Immunological Diseases, Guizhou Provincial People's Hospital, Guiyang, China.
  • Department of Neurology, Second Affiliated Hospital of Army Medical University (Xinqiao Hospital), Chongqing, China.
  • Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • The Second Department of Gastrointestinal Surgery, the Affiliated Hospital of North Sichuan Medical College, Sichuan, China.

ORCID-Profile: Yanfang Yang, Xiaoli Jin, Samina Ejaz Syed, Shufang Liang

Förderung

  • National Natural Science Foundation of China
  • the Strategic Cooperation Project between Sichuan University and Suining Municipal People's Government

Zitieren

APA

Yang, Y., Kong, T., Wang, B., Jin, X., Huang, L., Zhang, N., Tang, S., Syed, S. E., & Liang, S. (2026). SUMOylated DDX3 Promotes HBV Replication and Tumor Growth of Hepatocellular Carcinoma via TRIM28‐DDX3‐KLF4α Signaling Axis. Advanced Science. https://doi.org/10.1002/advs.78603

Vancouver

Yang Y, Kong T, Wang B, Jin X, Huang L, Zhang N, et al. SUMOylated DDX3 Promotes HBV Replication and Tumor Growth of Hepatocellular Carcinoma via TRIM28‐DDX3‐KLF4α Signaling Axis. Advanced Science. 2026. doi:10.1002/advs.78603

BibTeX
@article{Yang2026,
  author = {Yang, Yanfang and Kong, Ting and Wang, Binghan and Jin, Xiaoli and Huang, Lan and Zhang, Nan and Tang, Siyu and Syed, Samina Ejaz and Liang, Shufang},
  title = {SUMOylated DDX3 Promotes HBV Replication and Tumor Growth of Hepatocellular Carcinoma via TRIM28‐DDX3‐KLF4α Signaling Axis},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.78603}
}
Kostenlos starten →